The topoisomerase 1-interacting protein BTBD1 is essential for muscle cell differentiation

Cell Death and Differentiation

Volumn 11, Issue 11, 2004, Pages 1157-1165

  Pisani, D F ^a,b   Cabane, C ^a,b   Derijard, B ^a   Dechesne, C A ^b  

^a Valrose   (France)

^b CENTRE DE BIOCHIMIE   (France)

Author keywords

Adipogenesis; C2C12; Myogenesis

Indexed keywords

DNA TOPOISOMERASE; GENE PRODUCT; PROTEIN BTBD1; UNCLASSIFIED DRUG;

ADIPOCYTE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; IN VITRO STUDY; METABOLIC REGULATION; MOLECULAR CLONING; MOUSE; MUSCLE CELL; MYOTUBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

ADIPOCYTES; ANIMALS; AZO COMPOUNDS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; COLORING AGENTS; DNA TOPOISOMERASES, TYPE I; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; MUSCLES; PLASMIDS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RNA; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 8844239149     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401479     Document Type: Article

References (50)

1. Champoux JJ (2001) DNA topoisomerases: structure, function, and mechanism. Annu. Rev. Biochem. 70: 369-413
2. Nitiss JL (1998) Investigating the biological functions of DNA topoisomerases in eukaryotic cells. Biochim. Biophys. Acta 1400: 63-81
3. Wang JC (2002) Cellular roles of DNA topoisomerases: a molecular perspective. Nat. Rev. Mol. Cell Biol. 3: 430-z440
4. Wang JC (1996) DNA topoisomerases. Annu. Rev. Biochem. 65: 635-692
5. Castano IB, Brzoska PM, Sadoff BU, Chen H and Christman MF (1996) Mitotic chromosome condensation in the rDNA requires TRF4 and DNA topoisomerase I in Saccharomyces cerevisiae. Genes Dev. 10: 2564-2576
6. Shykind BM, Kim J, Stewart L, Champoux JJ and Sharp PA (1997) Topoisomerase I enhances TFIID-TFIIA complex assembly during activation of transcription. Genes Dev. 11: 397-407
7. Merino A, Madden KR, Lane WS, Champoux JJ and Reinberg D (1993) DNA topoisomerase I is involved in both repression and activation of transcription. Nature 365: 227-232
8. Rossi F, Labourier E, Forne T, Divita G, Derancourt J, Riou JF, Antoine E, Cathala G, Brunel C and Tazi J (1996) Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I. Nature 381: 80-82
9. Straub T, Grue P, Uhse A, Lisby M, Knudsen BR, Tange TO, Westergaard O and Boege F (1998) The RNA-splicing factor PSF/p54 controls DNA-topoisomerase I activity by a direct interaction. J. Biol. Chem. 273: 26261-26264
10. Alsner J, Svejstrup JQ, Kjeldsen E, Sorensen BS and Westergaard O (1992) Identification of an N-terminal domain of eukaryotic DNA topoisomerase I dispensable for catalytic activity but essential for in vivo function. J. Bol. Chem. 267:12408-12411
11. Bharti AK, Olson MO, Kufe DW and Rubin EH (1996) Identification of a nucleolin binding site in human topoisomerase I. J. Biol. Chem. 271: 1993-1997
12. Bjornsti MA, Benedetti P, Viglianti GA and Wang JC (1989) Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin. Cancer Res. 49: 6318-6323
13. Lee MP, Brown SD, Chen A and Hsieh TS (1993) DNA topoisomerase I is essential in Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 90: 6656-6660
14. Onishi Y, Azuma Y, Sato Y, Mizuno Y, Tadakuma T and Kizaki H (1993) Topoisomerase inhibitors induce apoptosis in thymocytes. Biochim. Biophys. Acta 1175: 147-154
15. Giaccone G, van Ark-Otte J, Scagliotti G, Capranico G, van der Valk P, Rubio G, Dalesio O, Lopez R, Zunino F, Walboomers J and Pinedo HM (1995) Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung. Biochim. Biophys. Acta 1264: 337-346
16. Goodlad GA and Clark CM (1993) Altered levels of histone H1(0) and DNA topoisomerase activity in the liver of the tumour-bearing rat. Biochem. Mol. Biol. Int. 30: 1043-1052
17. Goodlad GA and Clark CM (1995) H1 histone sub-type distribution and DNA topoisomerase activity in skeletal muscle of tumour-bearing rats. Cancer Lett. 98: 111-114
18. Husain I, Mohler JL, Seigler HF and Besterman JM (1994) Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res. 54: 539-546
19. Rowinsky EK, Adjei A, Donehower RC, Gore SD, Jones RJ, Burke PJ, Cheng YC, Grochow LB and Kaufmann SH (1994) Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia. J. Clin. Oncol. 12: 2193-2203
20. van der Zee AG, de Jong S, Keith WN, Hollema H, Boonstra H and de Vries EG (1994) Quantitative and qualitative aspects of topoisomerase I and II alpha and beta in untreated and platinum/cyclophosphamide treated malignant ovarian tumors. Cancer Res. 54: 749-755
21. Chen HJ, Hwong CL, Wang CH and Hwang J (2000) Degradation of DNA topoisomerase I by a novel trypsin-like serine protease in proliferating human T lymphocytes. J. Biol. Chem. 275: 13109-13117
22. Gobert C, Skladanowski A and Larsen AK (1999) The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53. Proc. Natl. Acad. Sci. USA 96: 10355-10360
23. Karayan L, Riou JF, Seite P, Migeon J, Cantereau A and Larsen CJ (2001) Human ARF protein interacts with topoisomerase I and stimulates its activity. Oncogene 20: 836-848
24. Wang Z and Roeder RG (1998) DNA topoisomerase I and PC4 can interact with human TFIIIC to promote both accurate termination and transcription reinitiation by RNA polymerase III. Mol. Cell 1: 749-757
25. Desai SD, Li TK, Rodriguez-Bauman A, Rubin EH and Liu LF (2001) Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells. Cancer Res. 61: 5926-5932
26. Desai SD, Liu LF, Vazquez-Abad D and D'Arpa P (1997) Ubiquitin-dependent destruction of topoisomerase I is stimulated by the antitumor drug camptothecin. J. Biol. Chem. 272: 24159-24164
27. Hwong CL, Chen CY, Shang HF and Hwang J (1993) Increased synthesis and degradation of DNA topoisomerase I during the initial phase of human T lymphocyte proliferation. J. Biol. Chem. 268: 18982-18986
28. Xu L, Yang L, Hashimoto K, Anderson M, Kohlhagen G, Pommier Y and D'Arpa P (2002) Characterization of BTBD1 and BTBD2, two similar BTB-domain-containing Kelch-like proteins that interact with Topoisomerase I. BMC Genomics 3: 1
29. Carim-Todd L, Sumoy L, Andreu N, Estivill X and Escarceller M (2001) Identification and characterization of BTBD1, a novel BTB domain containing gene on human chromosome 15q24. Gene 262: 275-281
30. Zollman S, Godt D, Prive GG, Couderc JL and Laski FA (1994) The BTB domain, found primarily in zinc finger proteins, defines an evolutionarily conserved family that includes several developmentally regulated genes in Drosophila. Proc. Natl. Acad. Sci. USA 91: 10717-10721
31. Bardwell VJ and Treisman R (1994) The POZ domain: a conserved protein-protein interaction motif. Genes Dev. 8: 1664-1677
32. Pietu G, Eveno E, Soury-Segurens B, Fayein NA, Mariage-Samson R, Matingou C, Leroy E, Dechesne C, Krieger S, Ansorge W, Reguigne-Arnould I, Cox D, Dehejia A, Polymeropoulos MH, Devignes MD and Auffray C (1999) The genexpress IMAGE knowledge base of the human muscle transcriptome: a resource of structural, functional, and positional candidate genes for muscle physiology and pathologies. Genome Res. 9: 1313-1320
33. Baroffio A, Aubry JP, Kaelin A, Krause RM, Hamann M and Bader CR (1993) Purification of human muscle satellite cells by flow cytometry. Muscle Nerve 16: 498-505
34. Yeow K, Phillips B, Dani C, Cabane C, Amri EZ and Derijard B (2001) Inhibition of myogenesis enables adipogenic trans differentiation in the C2C12 myogenic cell line. FEBS Lett. 506: 157-162
35. Grimaldi PA, Teboul L, Inadera H, Gaillard D and Amri EZ (1997) Trans-differentiation of myoblasts to adipoblasts: triggering effects of fatty acids and thiazolidinediones. Prostaglandins Leukot. Essent. Fatty Acids 57: 71-75
36. Desai SD, Zhang H, Rodriguez-Bauman A, Yang JM, Wu X, Gounder MK, Rubin EH and Liu LF (2003) Transcription-dependent degradation of topoisomerase I-DNA covalent complexes. Mol. Cell. Biol. 23: 2341-2350
37. Kimura K and Hirano T (1997) ATP-dependent positive supercoiling of DNA by 13S condensin: a biochemical implication for chromosome condensation. Cell 90: 625-634
38. Wang JC and Giaever GN (1988) Action at a distance along a DNA. Science 240: 300-304
39. Ulukan H, Muller MT and Swaan PW (2001) Downregulation of topoisomerase I in differentiating human intestinal epithelial cells. Int. J. Cancer 94: 200-207
40. Xu L, Yang L, Moitra PK, Hashimoto K, Rallabhandi P, Kaul S, Meroni G, Jensen JP, Weissman AM and D'Arpa P (2003) BTBD1 and BTBD2 colocalize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5delta. Exp. Cell Res. 288: 84-93
41. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, Wozney JM, Kim EG, Choi JY, Ryoo HM and Bae SC (2000) Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell. Biol. 20: 8783-8792
42. McKinsey TA, Zhang CL and Olson EN (2002) Signaling chromatin to make muscle. Curr. Opin. Cell Biol. 14: 763-772
43. Roy K, de la Serna IL and Imbalzano AN (2002) The myogenic basic helix-loop-helix family of transcription factors shows similar requirements for SWI/SNF chromatin remodeling enzymes during muscle differentiation in culture. J. Biol. Chem. 277: 33818-33824
44. McKinsey TA, Zhang CL, Lu J and Olson EN (2000) Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408: 106-111
45. Lu J, McKinsey TA, Zhang CL and Olson EN (2000) Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell 6: 233-244
46. Gerber AN, Klesert TR, Bergstrom DA and Tapscott SJ (1997) Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis. Genes Dev. 11: 436-450
47. Tkatchenko AV, Pietu G, Cros N, Gannoun-Zaki L, Auffray C, Leger JJ and Dechesne CA (2001) Identification of altered gene expression in skeletal muscles from Duchenne muscular dystrophy patients. Neuromuscular Disord. 11: 269-277
48. Cabane C, Englaro W, Yeow K, Ragno M and Derijard B (2003) Regulation of C2C12 myogenic terminal differentiation by MKK3/p38alpha pathway. Am. J. Physiol. Cell. Physiol. 284: C658-C666
49. Brunet A, Roux D, Lenormand P, Dowd S, Keyse S and Pouyssegur J (1999) Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J. 18: 664-674
50. Aubert J, Dessolin S, Belmonte N, Li M, McKenzie FR, Staccini L, Villageois P, Barhanin B, Vernallis A, Smith AG, Ailhaud G and Dani C (1999) Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade. J. Biol. Chem. 274: 24965-24972